Research Overview: Extra Super P-Force Sunrise
Extra Super P-Force Sunrise is a dual-action pharmaceutical compound that combines sildenafil citrate with dapoxetine hydrochloride for comprehensive laboratory investigations. This formulation enables researchers to examine the synergistic mechanisms of PDE5 inhibition alongside selective serotonin reuptake inhibition in preclinical models. The compound provides a unique research platform for studying vascular function and neurotransmitter modulation pathways simultaneously. Researchers investigating erectile dysfunction pathophysiology and premature ejaculation mechanisms will find this combination particularly valuable for comparative studies. The dual-component formulation allows for examination of how phosphodiesterase inhibition and serotonin regulation interact at the molecular level.
Laboratory Applications
Research teams utilise Extra Super P-Force Sunrise to investigate the complex interplay between vascular smooth muscle relaxation and central nervous system serotonin pathways. The sildenafil component enables detailed study of cyclic GMP signalling cascades, while dapoxetine facilitates examination of SERT transporter inhibition mechanisms. This combination proves essential for researchers developing novel therapeutic approaches to male sexual dysfunction disorders. Studies examining the pharmacokinetic interactions between PDE5 inhibitors and SSRIs benefit significantly from this pre-combined formulation. Research applications extend to investigations of nitric oxide signalling pathways and their modulation by selective serotonin reuptake mechanisms in laboratory settings.
Specification Data
| Parameter | Value |
|---|---|
| Chemical Classification | Dual PDE5/SERT inhibitor combination |
| Active Components | Sildenafil citrate + Dapoxetine HCl |
| Molecular Weight | Verify with supplier |
| CAS Registry | Verify with supplier |
| Storage Requirements | Room temperature, dry conditions |
| Research Grade | Laboratory standard |
Our Stroid UK Shop maintains comprehensive quality documentation for all pharmaceutical compounds. The erectile dysfunction research category includes various sildenafil analogues and combination formulations for comparative studies. Researchers also examine complementary compounds in our selective androgen receptor modulators and research peptides collections for comprehensive hormonal pathway investigations.
Research Compliance
Extra Super P-Force Sunrise is supplied exclusively for in-vitro laboratory research purposes. This pharmaceutical combination is not intended for human consumption, clinical application, or therapeutic use. Researchers must ensure appropriate institutional oversight and safety protocols when handling this dual-action compound. All studies should comply with relevant laboratory safety guidelines and institutional review board requirements for pharmaceutical research investigations.
